ASTMA Fees and Costs — SA Wellington Strategic Multi-Asset Portfolio, Class 1
Data updated: 2026-04-27
The net expense ratio is 0.81%: a 1.00% management fee plus 0.27% other expenses, less a 0.46% fee waiver. There are no sales loads or redemption fees. In fiscal 2020 the fund paid $42K in broker commissions, 0.0542% of average net assets, and portfolio turnover was 69%.
ASTMA Fees and Expenses
Annual operating expenses and sales charges of ASTMA. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 1.00% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.27% |
| Gross expense ratio | 1.27% |
| Fee waiver | −0.46% |
| Net expense ratio | 0.81% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
ASTMA Costs Over Time
On $10,000 invested in ASTMA, assuming 5% a year before costs, total costs come to $542 over 5 years, cutting the return by 0.91% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.81%) | $85 | $266 | $462 |
| Trading costs (broker commissions) | $6 | $18 | $31 |
| Lost growth on money paid in costs | $0 | $14 | $50 |
| Total costs | $91 | $298 | $542 |
| Value after costs | $10,409 | $11,279 | $12,221 |
| Impact on return, per year | 0.91% | 0.91% | 0.91% |
ASTMA Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2020.
- Explicit cost rate (commissions ÷ average net assets): 0.0542%
- Total broker commissions: $42K
- Bought from dealers (principal trades, not a cost): $616.2M
- Portfolio turnover (prospectus): 69%
- Securities lending: none during the year
ASTMA Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $6K | 19.65% |
| Goldman Sachs & Co. LLC | $5K | 15.38% |
| BofA Securities, Inc. | $4K | 13.50% |
| UBS Securities LLC | $4K | 12.41% |
| J.P. Morgan Securities LLC | $3K | 10.98% |
| Citigroup Global Markets Inc. | $2K | 7.55% |
| Credit Suisse Securities (USA) LLC | $2K | 6.86% |
| Jefferies LLC | $2K | 6.43% |
| RBC Capital Markets, LLC | $1K | 3.66% |
| Barclays Capital Inc. | $1K | 3.59% |
ASTMA Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Deutsche Bank Securities Inc. | $127.3M | 21.31% |
| BofA Securities, Inc. | $124.4M | 20.84% |
| Natwest Markets Securities Inc. | $121.5M | 20.35% |
| Barclays Capital Inc. | $104.3M | 17.47% |
| BNP Paribas Securities Corp. | $96.5M | 16.15% |
| Goldman Sachs & Co. LLC | $6.2M | 1.04% |
| Citigroup Global Markets Inc. | $4.4M | 0.73% |
| HSBC Securities (USA) Inc. | $4.2M | 0.71% |
| Morgan Stanley & Co. LLC | $4.2M | 0.70% |
| J.P. Morgan Securities LLC | $4.1M | 0.69% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.